Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 5 of 5 clinical reviews.
A clinician-focused guide to denosumab dosing, pharmacogenomics, and efficacy data in East Asian patients, including ethnicity-stratified subgroup results, BMI thresholds, and hypocalcemia risk.
Read clinical reviewEvidence-based guide to denosumab (Prolia) dosing in Hispanic and Latino patients, covering pharmacogenomics, bone density data, clinical trial subgroups, and monitoring recommendations.
Read clinical reviewA clinically detailed review of denosumab safety, pharmacogenomics, and dosing considerations specific to Hispanic and Latino patients, with ethnicity-stratified trial data, guideline citations, and practical prescribing guidance.
Read clinical reviewEvidence-based review of how denosumab (Prolia) performs in Black and African ancestry patients, including FREEDOM trial subgroup data, pharmacogenomic factors, and dosing considerations.
Read clinical reviewEvidence-based review of how denosumab (Prolia) safety, metabolism, and fracture outcomes may differ in South Asian populations, including pharmacogenomic considerations and clinical monitoring guidance.
Read clinical review